Cancer Family
Embryonal Neoplasm
CI-CAN-00000013Explore in graph →
Non-malignant285 active trials7 approved drugs73 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000013Explore in graph →
Clinical trials
1,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06502210 | Identification of New Gene Spliceosomes in Neuroblastoma | unknown | — | 20 | Affiliated Hospital of Nantong UniversityOTHER | 1 | Jul 16, 2024 | clinicaltrials |
| NCT06288802 | Study of Wilms Tumors Among Patients of Shefa Al-Orman Children Cancer Hospital | unknown | — | 50 | South Egypt Cancer InstituteOTHER | 1 | Mar 1, 2024 | clinicaltrials |
| NCT06275334 | Dinutuximab Beta at the HUS and the Toulouse Oncopole(DNB) | unknown | — | 40 | University Hospital, Strasbourg, FranceOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT03242382 | Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.(PalboSarc) | unknown | Phase 2 | 40 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT01811394 | Ion Irradiation of Sacrococcygeal Chordoma(ISAC) | unknown | Phase 2 | 100 | Heidelberg UniversityOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT03600649 | Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas | unknown | Phase 1 | 50 | Salarius Pharmaceuticals, LLCINDUSTRY | 1 | Nov 21, 2023 | clinicaltrials |
| NCT06140732 | Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma | unknown | Phase 2 | 30 | Xuanwu Hospital, BeijingOTHER | 1 | Nov 20, 2023 | clinicaltrials |
| NCT01586767 | Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy | unknown | N/A | 45 | Massachusetts General HospitalOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT04735289 | Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma(Metabol-Sarc) | unknown | — | 810 | Istituto Ortopedico RizzoliOTHER | 1 | Aug 4, 2023 | clinicaltrials |
| NCT05266196 | A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) | unknown | Phase 1 / Phase 2 | 10 | Salarius Pharmaceuticals, LLCINDUSTRY | 1 | Aug 1, 2023 | clinicaltrials |
| NCT02557750 | Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience | unknown | — | 35 | Assiut UniversityOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT02558244 | Impact of Image-defined Risk Factors on the Outcome of Patients With Neuroblastoma: A Retrospective Study | unknown | — | 100 | Assiut UniversityOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT02665676 | Embryonal Tumors of Infancy & Childhood: South Egypt Cancer Institute Experience | unknown | — | 420 | Assiut UniversityOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05707767 | A Prospective Study of Surgical Treatment Strategies for Chordoma | unknown | N/A | 100 | Xuanwu Hospital, BeijingOTHER | 1 | Jul 19, 2023 | clinicaltrials |
| NCT05755295 | Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma(EQUI-HIPPO) | unknown | N/A | 15 | University Hospital, ToulouseOTHER | 1 | Jul 13, 2023 | clinicaltrials |
| NCT05918432 | Determining Patterns In Study Experiences of Neuroblastoma Patients | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 1 | Jun 26, 2023 | clinicaltrials |
| NCT05850377 | 5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas | unknown | — | 90 | Sociedad de Lucha Contra el Cáncer del EcuadorOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT05781919 | Use of Virtual Reality for Surgical Planning in Neuroblastoma(VRNB) | unknown | N/A | 130 | Hospital Sant Joan de DeuOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT05782959 | Phase 1 Study of BCD-245 in Subjects With Neuroblastoma | unknown | Phase 1 | 24 | BiocadINDUSTRY | 1 | Mar 24, 2023 | clinicaltrials |
| NCT03561259 | A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects(OPTIMUM) | unknown | Phase 2 | 60 | Jubilant DraxImage Inc.INDUSTRY | 1 | Feb 16, 2023 | clinicaltrials |
| NCT05693519 | GastroIntestinal Cancer in Children and Adolescents(GICCA) | unknown | — | 2,500 | Paul G. Kemps, MDOTHER | 1 | Jan 23, 2023 | clinicaltrials |
| NCT03359005 | Irinotecan and Temozolomide for Ewing Sarcoma | unknown | Phase 2 | 60 | Peking University People's HospitalOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT05322187 | Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy(sPLENTY-pc) | unknown | Phase 2 / Phase 3 | 15 | RenJi HospitalOTHER | 1 | Apr 11, 2022 | clinicaltrials |
| NCT02013336 | Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors | unknown | Phase 1 | 30 | South Plains Oncology ConsortiumNETWORK | 1 | Mar 31, 2022 | clinicaltrials |
| NCT04049864 | DNA Vaccination Against Neuroblastoma | unknown | Early Phase 1 | 12 | Belarusian Research Center for Pediatric Oncology, Hematology and ImmunologyOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT05179850 | Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children | unknown | — | 400 | West China HospitalOTHER | 1 | Jan 20, 2022 | clinicaltrials |
| NCT05170282 | Deep Learning Magnetic Resonance Imaging Radiomics for Diagnostic Value of Hepatic Tumors in Infants | unknown | — | 200 | West China HospitalOTHER | 1 | Dec 27, 2021 | clinicaltrials |
| NCT05131763 | NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors | unknown | Phase 1 | 3 | Fudan UniversityOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT05125666 | Efficacy of Dual Task Training on Children With Ataxia After Medulloblastoma Resection | unknown | Phase 2 | 30 | Cairo UniversityOTHER | 1 | Nov 18, 2021 | clinicaltrials |
| NCT00983398 | Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors | unknown | Phase 1 / Phase 2 | 17 | OHSU Knight Cancer InstituteOTHER | 1 | Oct 26, 2021 | clinicaltrials |
| NCT02743429 | Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma | unknown | Phase 2 | 40 | University Medicine GreifswaldOTHER | 2 | Oct 4, 2021 | clinicaltrials |
| NCT04864821 | Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor | unknown | Early Phase 1 | 24 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 0 | May 6, 2021 | clinicaltrials |
| NCT04814758 | DWI in the Diagnosis of Histological Types of Nephroblastoma in Children | unknown | N/A | 230 | Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT00790413 | Haploidentical Stem Cell Transplantation in Neuroblastoma | unknown | Early Phase 1 | 15 | Lund University HospitalOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT04758455 | The Use of Immunohistochemical Staining for the Prediction of Wilms Tumour Progression and Recurrence | unknown | N/A | 75 | Mansoura UniversityOTHER | 1 | Feb 17, 2021 | clinicaltrials |
| NCT04017104 | Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging | unknown | — | 60 | British Columbia Cancer AgencyOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT04174820 | Child's Study of the Impact of PF Lesion on Motor Skills, Language, Cognitive Functioning and Social Cognition(CervIRM) | unknown | — | 145 | University Hospital, AngersOTHER_GOV | 1 | Nov 19, 2020 | clinicaltrials |
| NCT03734913 | A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors | unknown | Phase 1 | 65 | Guangdong Zhongsheng Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 22, 2020 | clinicaltrials |
| NCT01701479 | Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2)(LTI) | unknown | Phase 1 / Phase 2 | 288 | St. Anna KinderkrebsforschungOTHER | 7 | Jul 14, 2020 | clinicaltrials |
| NCT04388033 | Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. | unknown | Phase 1 / Phase 2 | 10 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 9, 2020 | clinicaltrials |
| NCT03288168 | Children's and Adolescents' Medulloblastoma Molecular Subgroups in China(CNOG-MB001) | unknown | — | 200 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Apr 17, 2020 | clinicaltrials |
| NCT03044769 | Congenital Lung Anomalies (CLA) Swiss Database(CLADatabase) | unknown | — | 100 | University Hospital, GenevaOTHER | 1 | Apr 16, 2020 | clinicaltrials |
| NCT03545542 | Investigating the Microbiome and Volatile Organic Compound Profile of Children With Neuroblastoma | unknown | N/A | 20 | Medical University of GrazOTHER | 1 | Feb 25, 2020 | clinicaltrials |
| NCT00503893 | Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies | unknown | — | 295 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 27, 2020 | clinicaltrials |
| NCT01991652 | Collaborative Wilms Tumour Africa Project | unknown | — | 400 | Amsterdam UMC, location VUmcOTHER | 3 | Jan 3, 2020 | clinicaltrials |
| NCT02856048 | Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer(PRESOV) | unknown | Phase 2 / Phase 3 | 11 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Dec 17, 2019 | clinicaltrials |
| NCT04065204 | Metabolomic Analysis of Body Fluid of Medulloblastoma in Children | unknown | — | 100 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 23, 2019 | clinicaltrials |
| NCT04042597 | Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma(CSSG-03) | unknown | Phase 2 | 60 | Peking University People's HospitalOTHER | 1 | Aug 5, 2019 | clinicaltrials |
| NCT02409576 | Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas(NKEXPSARC) | unknown | Phase 1 / Phase 2 | 20 | National University Hospital, SingaporeOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT03416517 | Anlotinib and Irinotecan for Ewing Sarcoma | unknown | Phase 1 / Phase 2 | 47 | Peking University People's HospitalOTHER | 1 | Feb 15, 2019 | clinicaltrials |
Data updated 22 days agoSource updated Jul 16, 2024source: clinicaltrials